Avalo Therapeutics AVTX
NASDAQ AVTX
$14.99 +0.04 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Sales of Property, Plant and Equipment (2023)

Updated

Avalo Therapeutics (AVTX) posted Sales of Property, Plant and Equipment of $25,000 for FY2023.

Analysis

Avalo Therapeutics (AVTX) Sales of Property, Plant and Equipment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Avalo Therapeutics 653.59 Mn 653.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 25,000.00
API Access

Avalo Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=AVTX&period=max&api_key=YOUR_API_KEY